Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy as a Medically Treatable Disease. Journal of Heart and Cardiovascular Science, [S. l.], v. 3, n. 1, p. 16–21, 2022. DOI: 10.5281/zenodo.22344598. Disponível em: https://pragmajournals.org/index.php/JHCS/article/view/168. Acesso em: 30 oct. 2026.